The association between major depressive disorder and cannabis use disorder: A meta-analysis and meta-regression analysis.
Major depressive disorder cannabis use is a critical area of study due to frequent co-occurrence. This meta-analysis examines prevalence estimates and clinical relevance. Understanding this association aids clinicians in patient care.
Differential Effects of Oleoyl Serine and HU-910 on Anxiety and Depression in WKY Rats
The endocannabinoid system depression anxiety connection is actively researched for therapeutic potential. This study investigates Oleoyl Serine and HU-910 effects on anxiety and depression behaviors in WKY rats. Results show sex-specific anxiolytic and…
Impact of Cannabinol, THCV, and CBD on Voluntary Alcohol Intake
The effect of cannabinol on alcohol consumption was studied to explore its potential in treating alcohol use disorder. This research also examined tetrahydrocannabivarin and cannabidiol for reducing alcohol intake. Findings suggest these…
Daily Anxiety and Depressive Symptoms Linked to Cannabis-Alcohol Co-Use
Rapidly changing cannabis legalization has increased cannabis use and co-use with alcohol. This study examines daily cannabis anxiety co-use among Black sexual and gender minority people. Findings highlight associations with anxiety and depressive…
Feasibility and Acceptability of a Physical Activity Intervention to Reduce Prenatal Cannabis Use: Results of an Open Pilot Trial
Cannabis use during pregnancy is rising despite health warnings. This study evaluates a physical activity intervention prenatal cannabis use to reduce consumption. Results show the intervention is feasible and acceptable for pregnant individuals.
Phase 1 Open-Label Pilot Trial of H4 dTMS for Moderate-to-Severe Cannabis Use Disorder
Deep repetitive transcranial magnetic stimulation (dTMS) is being studied as a treatment for cannabis use disorder (CUD). This phase 1 open-label pilot trial evaluated H4 dTMS combined with standard care for adults with moderate-to-severe CUD. The study…
Cannabidiol in Anorexia Nervosa: A Double-Blind Randomized Placebo Controlled Pilot Study
This cannabidiol anorexia nervosa study evaluates safety, pharmacokinetics, and symptom change in patients with anorexia nervosa. The randomized controlled trial used a double-blind design to assess cannabidiol effects. Results suggest cannabidiol is…
The Dual Roles of Natural Cannabidiol in Combating Oxidative Stress and Inflammation: A Potential Intestinal Guardian
Cannabidiol antioxidant intestinal protection is gaining attention for its therapeutic potential in gut health. CBD helps combat oxidative stress and inflammation in the gastrointestinal tract. This natural compound supports intestinal barrier integrity…
The role of cannabis-based medicinal products (CBMPs) in managing osteoarthritis symptoms: a scoping review of current evidence and future directions.
This review critically evaluates the therapeutic role of cannabis medicinal products osteoarthritis management. It focuses on clinical evidence and efficacy of various pharmacological doses and forms. The findings highlight potential benefits and safety…
Cannabidiol Synergizes with Methotrexate to Attenuate Rheumatoid Arthritis
This preclinical study explores the CBD methotrexate rheumatoid arthritis combination therapy in mice. The research highlights synergistic effects on inflammatory pathways and macrophage polarization. While promising, clinical trials are needed to…
